SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Ackerman JJH, Grove TH, Wong GG, et al. Mapping of metabolites in whole animals by 31P NMR using surface coils. Nature 1980;283:16770.
  • 2
    Prichard JW. MRS of the brain: prospects for clinical application. In: YoungIR, CharlesHC, eds. MR spectroscopy: clinical applications and techniques. London: Martin Dunitz, 1996:125.
  • 3
    Arnold DL, Matthews PM. Pratical aspects of clinical applications of MRS in the brain. In: YoungIR, CharlesHC, eds. MR spectroscopy: clinical applications and techniques. London: Martin Dunitz, 1996:13959.
  • 4
    De Certaines JD, Bovee WMMJ, Podo F. Magnetic resonance spectroscopy in biology and medicine: functional and pathological tissue characterization. New York: Pergamon Press, 1992.
  • 5
    Petroff OAC, Pleban LA, Spencer DD. Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain. Magn Reson Imaging 1995;13:1197211.
  • 6
    Gadian DG. Nuclear magnetic resonance and its applications to living systems. 2nd ed. Oxford: Oxford University Press, 1995.
  • 7
    Laxer KD, Hubesch B, Sappey-Marinier D, et al. Increased pH and inorganic phosphate in temporal seizure foci demonstrated by 31P MRS. Epilepsia 1992;33:61823.
  • 8
    Chu WJ, Hetherington HP, Kuzniecky RI, et al. Lateralization of human temporal lobe epilepsy by 31P NMR spectroscopic imaging at 4.1 T. Neurology 1998;51:479.
  • 9
    Garcia PA, Laxer KD, Van Der Grond J, et al. Phosphorus magnetic resonance spectroscopic imaging in patients with frontal lobe epilepsy. Ann Neurol 1994;35:21721.
  • 10
    Hanstock CC, Rothman DL, Prichard JW, et al. Spatially localized 1H NMR spectra of metabolites in the human brain. Proc Natl Acad Sci U S A 1988;85:18215.
  • 11
    Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991;45:3745.
  • 12
    Moffett JR, Aryan MA, Namboodiri MAA, et al. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 1991;2:1314.
  • 13
    De Stefano N, Matthews PM, Arnold DL. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995;34:7217.
  • 14
    Hugg JW, Kuzniecky RI, Gilliam FG, et al. Normalization of contralateral metabolic function following temporal lobectomy demonstrated by H-1 magnetic resonance spectroscopic imaging. Ann Neurol 1996;40:2369.
  • 15
    Cendes F, Andermann F, Dubeau F, Matthews PM, Arnold DL. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy: evidence from proton MR spectroscopic imaging. Neurology 1997;49:152533.
  • 16
    Arnold DL, Matthews PM, Francis GS, et al. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol 1992;31:23541.
  • 17
    Preul MC, Caramanos Z, Collins DL, et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 1996;2:3235.
  • 18
    Arnold DL, Shoubridge EA, Villemure JG, et al. Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo: preliminary observations on tumor grading. NMR Biomed 1990;3:1849.
  • 19
    Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996;84:44958.
  • 20
    Petroff OA, Novotny EJ, Avison M, et al. Cerebral lactate turnover after electroshock: in vivo measurements by 1H/13C magnetic resonance spectroscopy. J Cereb Blood Flow Metab 1992;12:10229.
  • 21
    Petroff OA, Prichard JW, Ogino T, et al. Combined 1H and 31P nuclear magnetic resonance spectroscopic studies of bicuculline-induced seizures in vivo. Ann Neurol 1986;20:18593.
  • 22
    Young RS, Petroff OA, Chen B, et al. Brain energy state and lactate metabolism during status epilepticus in the neonatal dog: in vivo 31P and 1H nuclear magnetic resonance study. Pediatr Res 1991;29:1915.
  • 23
    Ebisu T, Rooney WD, Graham SH, et al. N-Acetylaspartate as an in vivo marker of neuronal viability in kainate-induced status epilepticus: 1H magnetic resonance spectroscopic imaging. J Cereb Blood Flow Metab 1994;14:37382.
  • 24
    Najm IM, Wang Y, Shedid D, et al. MRS metabolic markers of seizures and seizure-induced neuronal damage. Epilepsia 1998;39:24450.
  • 25
    Petroff OA, Spencer DD, Alger JR, et al. High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy. Neurology 1989;39:1197202.
  • 26
    Matthews PM, Andermann F, Arnold DL. A proton magnetic resonance spectroscopy study of focal epilepsy in humans. Neurology 1990;40:9859.
  • 27
    Cendes F, Andermann F, Silver K, et al. Imaging of axonal damage in vivo in Rasmussen's syndrome. Brain 1995;118:7538.
  • 28
    Cendes F, Andermann F, Preul M, et al. Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images. Ann Neurol 1994;35:2116.
  • 29
    Hugg JW, Laxer KD, Matson GB, et al. Neuron loss localizes human temporal lobe epilepsy by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 1993;34:78894.
  • 30
    Connelly A, Jackson GD, Duncan JS, et al. Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology 1994;44:14117.
  • 31
    Cendes F, Caramanos Z, Andermann F, et al. Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateralization of temporal lobe epilepsy: a series of 100 patients. Ann Neurol 1997;42:73746.
  • 32
    Cendes F, Andermann F, Dubeau F, et al. Proton magnetic resonance spectroscopic imgaging and MRI volumetric studies for lateralization of temporal lobe epilepsy. Magn Reson Imaging 1995;13:118791.
  • 33
    Cendes F, Stanley JA, Dubeau F, et al. Proton magnetic resonance spectroscopic imaging for discrimination of absence and complex partial seizures. Ann Neurol 1997;41:7481.
  • 34
    Vainio P, Usenius JP, Vapalahti M, et al. Reduced N-acetylaspartate concentration in temporal lobe epilepsy by quantitative 1H MRS in vivo. Neuroreport 1994;5:17336.
  • 35
    Cross JH, Connelly A, Jackson GD, et al. Proton magnetic resonance spectroscopy in children with temporal lobe epilepsy. Ann Neurol 1996;39:10713.
  • 36
    Ng TC, Comair YG, Xue M, et al. Temporal lobe epilepsy: presurgical localization with proton chemical shift imaging. Radiology 1994;193:46572.
  • 37
    Hetherington H, Kuzniecky R, Pan J, et al. Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T. Ann Neurol 1995;38:396404.
  • 38
    Breiter SN, Arroyo S, Mathews VP, et al. Proton MR spectroscopy in patients with seizure disorders. AJNR Am J Neuroradiol 1994;15:37384.
  • 39
    Kuzniecky R, Hugg JW, Hetherington H, et al. Relative utility of 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy. Neurology 1998;51:6671.
  • 40
    Li LM, Caramanos Z, Cendes F, et al. Lateralization of temporal lobe epilepsy (TLE) and discrimination of TLE from extra-TLE using pattern analysis of magnetic resonance spectroscopic and volumetric data. Epilepsia 2000;41:83242.
  • 41
    Li LM, Cendes F, Bastos AC, et al. Neuronal metabolic dysfunction in patients with cortical developmental malformations: a proton magnetic resonance spectroscopic imaging study. Neurology 1998;50:7559.
  • 42
    Kuzniecky R, Hetherington H, Pan J, et al. Proton spectroscopic imaging at 4.1 Tesla in patients with malformations of cortical development and epilepsy. Neurology 1997;48:101824.
  • 43
    Garcia PA, Laxer KD, Van Der Grond J, et al. Proton magnetic resonance spectroscopic imaging in patients with frontal lobe epilepsy. Ann Neurol 1995;37:27981.
  • 44
    Stanley JA, Cendes F, Dubeau F, et al. Proton magnetic resonance spectroscopic imaging in patients with extratemporal epilepsy. Epilepsia 1998;39:26773.
  • 45
    Achten E, Santens P, Boon P, et al. Single-voxel proton MR spectroscopy and positron emission tomography for lateralization of refractory temporal lobe epilepsy [see comments]. AJNR Am J Neuroradiol 1998;19:18.
  • 46
    Ende GR, Laxer KD, Knowlton RC, et al. Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging. Radiology 1997;202:80917.
  • 47
    Li LM, Cendes F, Andermann F, et al. Prognostic value of proton MR spectroscopic imaging for surgical outcome in patients with intractable temporal lobe epilepsy and bilateral hippocampal atrophy. Ann Neurol 2000;47:195200.
  • 48
    Kuzniecky R, Hugg J, Hetherington H, et al. Predictive value of 1H MRSI for outcome in temporal lobectomy. Neurology 1999;53:69498.
  • 49
    O'Brien TJ, Newton MR, Cook MJ, et al. Hippocampal atrophy is not a major determinant of regional hypometabolism in temporal lobe epilepsy. Epilepsia 1997;38:7480.
  • 50
    Henry TR, Babb TL, Engel J Jr, et al. Hippocampal neuronal loss and regional hypometabolism in temporal lobe epilepsy. Neurology 1994;36:9257.
  • 51
    Lu D, Margouleff C, Rubin E, et al. Temporal lobe epilepsy: correlation of proton magnetic resonance spectroscopy and 18F-fluorodeoxyglucose positron emission tomography. Magn Reson Med 1997;37:1823.
  • 52
    Knowlton RC, Kuzniecky R, Abou-Khalil B, et al. Hippocampal specific metabolic disturbances in mesial temporal lobe epilepsy measured with FDG-PET and 1H-MRSI [Abstract]. Neurology 2000;54(suppl 3):A79.
  • 53
    Maton B, Londono A, Sawrie S, et al. Postictal stability of proton magnetic resonance spectroscopy imaging ((1)H-MRSI) ratios in temporal lobe epilepsy. Neurology 2001;56:2513.
  • 54
    Li LM, Cendes F, Andermann F, et al. Spatial extent of neuronal metabolic dysfunction measured by proton MR spectroscopic imaging in patients with localization-related epilepsy. Epilepsia 2000;41:66674.
  • 55
    Serles W, Li LM, Caramanos Z, et al. Relation of interictal spike frequency to 1H-MRSI-measured NAA/Cr. Epilepsia 1999;40:18217.
  • 56
    Peeling J, Sutherland G. 1H magnetic resonance spectroscopy of extracts of human epileptic neocortex and hippocampus. Neurology 1993;43:58994.
  • 57
    Maton B, Gilliam F, Sawrie S, et al. Correlation of scalp EEG and 1H-MRS metabolic abnormalities in temporal lobe epilepsy. Neuroimage 2001 (in press).
  • 58
    Serles W, Li LM, Antel SB, et al. Time course of postoperative recovery of N-acetyl-aspartate in temporal lobe epilepsy. Epilepsia 2001;42:1907.DOI: 10.1046/j.1528-1157.2001.01300.x
  • 59
    Vermathen P, Laxer KD, Matson GB, et al. Hippocampal structures: anteroposterior N-acetylaspartate differences in patients with epilepsy and control subjects as shown with proton MR spectroscopic imaging. Radiology 2000;214:40310.
  • 60
    Garcia PA, Laxer KD, Van Der Grond J, et al. Correlation of seizure frequency with N-acetyl-aspartate levels determined by 1H magnetic resonance spectroscopic imaging. Magn Reson Imaging 1997;15:4758.
  • 61
    Tasch E, Cendes F, Li LM, et al. Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy [see comments]. Ann Neurol 1999;45:56876.DOI: 10.1002/1531-8249(199905)45:5<568::aid-ana4>3.0.co;2-p
  • 62
    Preul MC, Leblanc R, Cendes F, et al. Function and organization in dysgenic cortex: case report. J Neurosurg 1997;87:11321.
  • 63
    Miller SP, Li LM, Cendes F, et al. Neuronal dysfunction in children with newly diagnosed temporal lobe epilepsy. Pediatr Neurol 2000;22:2816.
  • 64
    Connelly A, Van Paesschen W, Porter DA, et al. Proton magnetic resonance spectroscopy in MRI-negative temporal lobe epilepsy. Neurology 1998;51:616.
  • 65
    Pan JW, Mason GF, Pohost GM, et al. Spectroscopic imaging of human brain glutamate by water-suppressed J-refocused coherence transfer at 4.1 T. Magn Reson Med 1996;36:712.
  • 66
    Novotny E, Ashwal S, Shevell M. Proton magnetic resonance spectroscopy: an emerging technology in pediatric neurology research. Pediatr Res 1998;44:110.
  • 67
    Novotny EJ, Hyder F, Mason GF, et al. Cerebral GABA in pediatric epilepsy. Pediatr Res 2000;47:463A.
  • 68
    Novotny EJ, Hyder F, Shevell M, et al. GABA changes with vigabatrin in the developing human brain. Epilepsia 1999;40:4626.
  • 69
    Petroff OA, Hyder F, Rothman DL, et al. Effects of gabapentin on brain GABA, homocarnosine, and pyrrolidinone in epilepsy patients. Epilepsia 2001;41:67580.
  • 70
    Pan JW, Bebin EM, Chu WJ, Hetherington HP. Ketosis and epilepsy: 31P spectroscopic imaging at 4.1 T. Epilepsia 1999;40:7037.
  • 71
    Gadian DG, Isaacs EB, Cross JH, et al. Lateralization of brain function in childhood revealed by magnetic resonance spectroscopy. Neurology 1996;46:9747.
  • 72
    Martin RC, Sawrie S, Hugg J, et al. Cognitive correlates of 1H MRSI-detected hippocampal abnormalities in temporal lobe epilepsy. Neurology 1999;53:20528.
  • 73
    Incisa della Rocchetta A, Gadian DG, Connelly A, et al. Verbal memory impairment after right temporal lobe surgery: role of contralateral damage as revealed by 1H magnetic resonance spectroscopy and T2 relaxometry. Neurology 1995;45:797802.
  • 74
    Sawrie SM, Martin RC, Gilliam FG, et al. Visual confrontation naming and hippocampal function: a neural network study using quantitative (1)H magnetic resonance spectroscopy. Brain 2000;123:77080.
  • 75
    Sawrie SM, Martin RC, Gilliam F, et al. Nonlinear trends in hippocampal metabolic function and verbal memory: evidence of cognitive reserve in temporal lobe epilepsy. Epilepsy Behav 2000;1:106111.
  • 76
    Duc CO, Trabesinger AH, Weber OM, et al. Quantitative 1H MRS in the evaluation of mesial temporal lobe epilepsy in vivo. Magn Reson Imaging 1998;16:96979.